Medicare Advantage plans for the first time next year will be allowed to make beneficiaries use the cheapest doctor-administered drugs first, and step therapy could be used across doctor-administered drugs and retail drugs, but plans also must share half of savings from step therapy with beneficiaries, administration officials said Tuesday (Aug. 7). The combination of policies is both new and in keeping with the administration's goal to let plans negotiate drug prices in Part B with use-management tools and to...